Intellipharmaceutics International (IPCIF) Earnings Date, Estimates & Call Transcripts → Breaking News: Elon Musk Invents New Type of A.I. (Shocking) (From InvestorPlace) (Ad) Free IPCIF Stock Alerts $0.06 0.00 (0.00%) (As of 05/17/2024 ET) Add Compare Share Share EarningsStock AnalysisChartEarningsFinancialsSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsSEC FilingsShort Interest Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueIPCIF Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.IPCIF Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad True Market InsidersMy #1 investment for 2024It’s something you use every single day and don’t even know it.Click here to see my #1 investment for 2024. IPCIF Earnings Date and InformationIntellipharmaceutics International has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, June 3rd, 2024 based off prior year's report dates.Read More Get Intellipharmaceutics International Earnings AlertsEnter your email address below to receive the latest news and earnings results for IPCIF and its competitors with MarketBeat's FREE daily newsletter. Intellipharmaceutics International Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 6/3/2024Estimated)------- 10/16/2023Q3 2023-($0.06)($0.06)($0.06)-$0.07 million6/6/2023Q1 2023-($0.01)($0.01)($0.01)-$0.33 million10/14/2022Q3 2022-($0.01)($0.01)($0.01)-$0.02 million7/21/2022Q2 2022-($0.05)($0.05)($0.07)--4/14/2022Q1 2022-($0.03)($0.03)($0.03)-$0.08 million2/28/2022Q4 2021-($0.17)($0.17)($0.17)-- Get the Latest News and Ratings for IPCIF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Intellipharmaceutics International and its competitors with MarketBeat's FREE daily newsletter. 10/15/2021Q3 2021-($0.04)($0.04)($0.04)--7/15/2021Q2 2021-($0.04)($0.04)($0.04)-$0.09 million Intellipharmaceutics International Earnings - Frequently Asked Questions When is Intellipharmaceutics International's earnings date? Intellipharmaceutics International has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, June 3rd, 2024 based off last year's report dates. Learn more on IPCIF's earnings history. How much revenue does Intellipharmaceutics International generate each year? Intellipharmaceutics International (OTCMKTS:IPCIF) has a recorded annual revenue of $660,000.00. How much profit does Intellipharmaceutics International generate each year? Intellipharmaceutics International (OTCMKTS:IPCIF) has a recorded net income of -$2.89 million. IPCIF has generated -$0.16 earnings per share over the last four quarters. More Earnings Resources from MarketBeat Related Companies: Clearmind Medicine Earnings Bio-Path Earnings Galmed Pharmaceuticals Earnings PaxMedica Earnings Qualigen Therapeutics Earnings Dermata Therapeutics Earnings Allarity Therapeutics Earnings PainReform Earnings 180 Life Sciences Earnings Salarius Pharmaceuticals Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Baidu Stock Earnings Prove Ray Dalio Right about China?Home Depot: Earnings Mixed, Wait to Buy the DipTraders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution This page (OTCMKTS:IPCIF) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersObama’s Forever Term [exposed]Porter & Company4 Cryptos BETTER than BitcoinTrue Market InsidersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingElon’s New Device is About to Shock the WorldInvestorPlaceMissed NVDA? Buy this AI stock NOWChaikin AnalyticsProtect Your Bank Account Before It’s Too LateWeiss RatingsUrgent Nvidia WarningAltimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Intellipharmaceutics International Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.